These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549 [Abstract] [Full Text] [Related]
4. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC. Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [Abstract] [Full Text] [Related]
14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D, Antoniou G, Karakitsos P, Kalogirou O, Antoniou D, Giannikos L. Int J Fertil Menopausal Stud; 1996 Jun 30; 41(6):522-7. PubMed ID: 9010746 [Abstract] [Full Text] [Related]
16. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ. Gu Z, Zhu P, Luo H, Zhu X, Zhang G, Wu S. Contraception; 1995 Jul 30; 52(1):57-61. PubMed ID: 8521716 [Abstract] [Full Text] [Related]
18. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J, Konje JC, Hickey M. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400 [Abstract] [Full Text] [Related]
19. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism? Mandelin E, Koistinen H, Koistinen R, Affandi B, Seppälä M. Hum Reprod; 1997 Dec 07; 12(12):2671-5. PubMed ID: 9455833 [Abstract] [Full Text] [Related]